Ferah Yıldız, Diclehan Orhan, Kader Karlı Oğuz, Mustafa Cengiz, Canan Akyüz, Murat Gürkaynak, Melis Gültekin, Çağlayan Selenge Bedük Esen, G. Burça Aydın

Ewing sarcoma in an infant and review of the literature

Ewing sarcoma (ES) is a rare tumor in infants and prognosis is controversial.There are no standard recommendations for treatment in such very youngpatients. Generally, radiotherapy (RT) is not a part of treatment in infantsdue to the risk of severe late side effects. In this case report, we report a7-month-old boy with diagnosis of left mastoid bone ES with lung metastasesat diagnosis, showing a rapidly fatal outcome despite aggressive systemicchemotherapy and RT without surgery.

PDF

___

1. Wong T, Goldsby RE, Wustrack R, Cash T, Isakoff MS, DuBois SG. Clinical features and outcomes of infants with Ewing sarcoma under 12 months of age. Pediatr Blood Cancer 2015; 62: 1947-1951.
2. Rodriguez-Galindo C, Liu T, Krasin MJ, et al. Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies. Cancer 2007; 110: 375-384.
3. van den Berg H, Dirksen U, Ranft A, Jurgens H. Ewing tumors in infants. Pediatr Blood Cancer 2008; 50: 761-764.
4. Maygarden SJ, Askin FB, Siegal GP, et al. Ewing sarcoma of bone in infants and toddlers. A clinicopathologic report from the Intergroup Ewing's Study. Cancer 1993; 71: 2109-2118.
5. Duchman KR, Gao Y, Miller BJ. Prognostic factors for survival in patients with Ewing's sarcoma using the surveillance, epidemiology, and end results (SEER) program database. Cancer Epidemiol 2015; 39: 189-195.
6. Kim SY, Tsokos M, Helman LJ. Dilemmas associated with congenital ewing sarcoma family tumors. J Pediatr Hematol Oncol 2008; 30: 4-7.
7. Akcali M, Yapicioglu H, Akay E, et al. A congenital soft tissue Ewing sarcoma in a newborn patient. Turk J Pediatr 2017; 59: 76-79.
8. Salunke PS, Gupta K, Malik V, et al. Primary Ewing's sarcoma of cranial bones: analysis of ten patients. Acta Neurochir (Wien) 2011; 153: 1477-1485.
9. Egan G, Pierro J, Madhusoodhan PP, Ilyas G, Cohen B, Bhatla T. Primary Ewing sarcoma of the mastoid: A novel case mimicking cute mastoiditis. J Pediatr Hematol Oncol 2018; 40: 148-151.
10. Garcia-Perez EA, Nunez-Ferrer P. Primary intracranial Ewing's sarcoma of the mastoid bone. A case report. Rev Neurol 2003; 36: 340-342.
11. Zimmermann JL. Ewing Sarcoma of the mastoid. Penn Med J 1934; 37: 654-656.
12. Yang MJ, Whelan R, Madden J, et al. Intracranial Ewing sarcoma: four pediatric examples. Childs Nerv Syst 2018; 34: 441-448.
13. Choudhury KB, Sharma S, Kothari R, Majumder A. Primary extraosseous intracranial Ewing's sarcoma: Case report and literature review. Indian J Med Paediatr Oncol 2011; 32: 118-121.
14. Ahmed SK, Randall RL, DuBois SG, et al. Identification of patients with localized Ewing sarcoma at higher risk for local failure: A report from the Children's Oncology Group. Int J Radiat Oncol Biol Phys 2017; 99: 1286-1294.
15. Becker RG, Gregianin LJ, Galia CR, et al; Brazilian Collaborative Study Group of Ewing Family of Tumors – EWING1 and the Brazilian Society of Pediatric Oncology – SOBOPE. What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group - EWING1. BMC Cancer 2017; 17: 420.
16. Bacci G, Longhi A, Briccoli A, Bertoni F, Versari M, Picci P. The role of surgical margins in treatment of Ewing's sarcoma family tumors: experience of a single institution with 512 patients treated with adjuvant and neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys 2006; 65: 766-772.
17. Carlotti CGJ, Drake JM, Hladky JP, Teshima I, Becker LE, Rutka JT. Primary Ewing's sarcoma of the skull in children. Utility of molecular diagnostics, surgery and adjuvant therapies. Pediatr Neurosurg 1999; 31: 307-315.
18. Sharib JM, Cyrus J, Horvai A, et al. Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma. Pediatr Blood Cancer 2012; 59: 611-616.
19. Nesbit ME Jr, Gehan EA, Burgert EO Jr, et al. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study. J Clin Oncol 1990; 8: 1664-1674.
20. Paulino AC, Nguyen TX, Mai WY, Teh BS, Wen BC. Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma. Pediatr Blood Cancer 2007; 49: 145-148.
21. Talleur AC, Navid F, Spunt SL, et al. Limited margin radiotherapy for children and young adults with Ewing sarcoma achieves high rates of local tumor control. Int J Radiat Oncol Biol Phys 2016; 96: 119- 126.
22. Esiashvili N, Goodman M, Marcus RBJr. Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data. J Pediatr Hematol Oncol 2008; 30: 425-430.
23. Paulussen M, Ahrens S, Burdach S, et al. Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. Ann Oncol 1998; 9: 275-281.